Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:43PM ET
5.24
Dollar change
+0.11
Percentage change
2.17
%
Index- P/E- EPS (ttm)-3.15 Insider Own3.03% Shs Outstand5.32M Perf Week27.49%
Market Cap27.88M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float5.15M Perf Month35.05%
Income-16.35M PEG- EPS next Q-0.68 Inst Own9.18% Short Float2.40% Perf Quarter77.62%
Sales0.11M P/S253.42 EPS this Y52.70% Inst Trans-63.33% Short Ratio4.05 Perf Half Y80.69%
Book/sh3.83 P/B1.37 EPS next Y- ROA-54.02% Short Interest0.12M Perf Year-6.03%
Cash/sh4.14 P/C1.26 EPS next 5Y- ROE-58.40% 52W Range2.31 - 5.95 Perf YTD87.81%
Dividend Est.- P/FCF- EPS past 5Y19.47% ROI-80.28% 52W High-11.93% Beta1.05
Dividend TTM- Quick Ratio8.69 Sales past 5Y-67.27% Gross Margin73.94% 52W Low126.83% ATR (14)0.40
Dividend Ex-Date- Current Ratio8.69 EPS Y/Y TTM-50.27% Oper. Margin-13610.84% RSI (14)72.68 Volatility11.75% 10.83%
Employees17 Debt/Eq0.00 Sales Y/Y TTM-78.00% Profit Margin-14867.29% Recom1.00 Target Price33.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-0.82% Payout- Rel Volume2.20 Prev Close5.13
Sales Surprise- EPS Surprise-8.51% Sales Q/Q- EarningsMar 08 AMC Avg Volume30.52K Price5.24
SMA2026.16% SMA5030.50% SMA20043.25% Trades Volume45,786 Change2.17%
Date Action Analyst Rating Change Price Target Change
Jun-24-21Initiated Cantor Fitzgerald Overweight $3
Dec-10-20Upgrade Ladenburg Thalmann Neutral → Buy $3
Jan-12-18Reiterated H.C. Wainwright Buy $10 → $3
Jan-11-18Downgrade Canaccord Genuity Buy → Hold $11 → $2
Dec-08-17Resumed H.C. Wainwright Buy $10
Oct-07-16Initiated H.C. Wainwright Buy $25
Jul-22-15Initiated ROTH Capital Buy $36
Jun-23-15Initiated Canaccord Genuity Buy $15
Today 08:00AM
Mar-25-24 08:00AM
Mar-07-24 02:52PM
08:00AM
Mar-06-24 08:00AM
08:00AM Loading…
Feb-06-24 08:00AM
Feb-02-24 08:00AM
Jan-18-24 08:00AM
Dec-19-23 08:00AM
Nov-13-23 02:45PM
Nov-08-23 08:17AM
08:00AM
Nov-01-23 08:00AM
Oct-26-23 08:00AM
Oct-23-23 07:00PM
04:05PM Loading…
Sep-19-23 04:05PM
Aug-16-23 06:02AM
Aug-10-23 08:09AM
08:00AM
Jul-31-23 06:13AM
Jul-27-23 06:30AM
Jun-14-23 08:00AM
Jun-07-23 08:00AM
May-19-23 09:14AM
May-16-23 07:00AM
May-11-23 06:23AM
06:00AM
Apr-03-23 08:00AM
Mar-16-23 06:00AM
Mar-10-23 08:30AM
08:30AM Loading…
08:30AM
Jan-16-23 08:06AM
Jan-05-23 08:00AM
Dec-19-22 08:00AM
Nov-30-22 04:28AM
Nov-09-22 08:00AM
Nov-03-22 08:00AM
Oct-11-22 08:00AM
Sep-27-22 01:21PM
Sep-26-22 11:39AM
08:00AM
Sep-22-22 04:10PM
Sep-15-22 08:00AM
Aug-10-22 06:04AM
Aug-09-22 06:41AM
Aug-08-22 08:00AM
Jul-11-22 08:00AM
Jun-14-22 08:00AM
Jun-06-22 04:00PM
May-20-22 07:12AM
May-12-22 10:55AM
08:00AM
May-10-22 11:30AM
May-09-22 08:00AM
May-04-22 06:34AM
Apr-11-22 08:00AM
Mar-29-22 07:34PM
07:05AM
Mar-11-22 04:26AM
Mar-09-22 08:00AM
Mar-01-22 08:00AM
Feb-25-22 07:42AM
Feb-03-22 08:00AM
Jan-27-22 08:00AM
Jan-05-22 08:00AM
Dec-22-21 08:00AM
Nov-19-21 09:04AM
Nov-11-21 10:00AM
Nov-10-21 08:00AM
Nov-08-21 08:18AM
Nov-04-21 08:00AM
Nov-01-21 08:00AM
Oct-19-21 07:00AM
Oct-18-21 12:15PM
07:00AM
Oct-05-21 08:00AM
Sep-28-21 08:00AM
Sep-20-21 08:00AM
Sep-01-21 08:00AM
Aug-31-21 05:43AM
Aug-25-21 06:30AM
Aug-09-21 07:12AM
Aug-05-21 08:00AM
Jul-15-21 09:00AM
Jul-14-21 04:00PM
Jul-06-21 08:00AM
Jun-23-21 08:00AM
Jun-16-21 08:00AM
Jun-14-21 08:00AM
Jun-07-21 08:00AM
May-27-21 05:31AM
May-26-21 12:44PM
08:00AM
May-25-21 08:32PM
May-24-21 05:40AM
May-19-21 05:04AM
May-06-21 08:00AM
Mar-22-21 08:41AM
Mar-11-21 08:00AM
08:00AM
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel Mahesh V.CEO and PresidentMay 25 '23Buy5.038,70643,791107,418May 25 03:10 PM